Suspected SARS-CoV-2 infection with fever and coronary heart disease: A case report.

paythelady.612 shared this article with you from Inoreader Suspected SARS-CoV-2 infection with fever and coronary heart disease: A case report. Μέσω pubmed: "world j clin cases"... Related Articles Suspected SARS-CoV-2 infection with fever and coronary heart disease: A case report. World J Clin Cases. 2020 Dec 06;8(23):6056-6063 Authors: Gong JR, Yang JS, He YW, Yu KH, Liu J, Sun RL Abstract BACKGROUND: The coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Suspected cases accounted for a large proportion in the early stage of the COVID-19 outbreak. The deviation of the nucleic acid test by throat swab (the current gold standard of COVID-19) caused by variation in sampling techniques and reagent kits and coupled with nonspecific clinical manifestations make confirmation of the suspected cases difficult. Proper management of the suspected cases of COVID-19 is crucial for disease control. CASE SUMMARY: A 65-year-old male presented with fever, lymphopenia, and chest computed tomography (CT) images similar to COVID-19 after percutaneous coronary intervention. The patient was diagnosed as having bacterial pneumonia with cardiogenic pulmonary edema instead of COVID-19. This was based on four negative results for throat swab detection of SARS-CoV-2 nucleic acid using reverse transcriptase-polymerase chain reaction assay and one negative result for serological antibody of SARS-CoV-2 with the serological assay. Additionally, the distribution of ground-glass opacities and thickened blood vessels from the CT images differed from COVID-19 features, which further supported the exclusion of COVID-19. CONCLUSION: Distinguishing COVID-19 patients from those with bacterial pneumonia with cardiogenic pulmonary edema can be difficult. Therefore, it requires serious identification. PMID: 33344605 [PubMed] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.